SCOTT ROBERT A bought ARQT

October 23, 2026 · Form 4 insider transaction

SCOTT ROBERT A bought 2,819 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,819
Price
$0.00
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 23, 2026
Filing dateOctober 28, 2026
Shares owned after2,819
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.

View the original Form 4 on SEC EDGAR